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Background/aims: To describe risk factors associated with primary open-angle glaucoma 
(POAG) in Japanese subjects who participated in community health screenings.
Methods: Residents of Akita, Japan, participating in a community health checkup were selected 
to undergo a comprehensive ophthalmic examination. Glaucoma was diagnosed based on optic 
disk appearance, perimetric results, and other ocular findings. Systemic blood pressure and 
intraocular pressure were measured and ocular perfusion pressure was calculated. Logistic 
regression analysis was performed to determine risk factors for POAG patients.
Results and conclusion: Of the 710 subjects examined, 26 had POAG. The estimated 
prevalence of POAG was 3.7%. After adjusting for age, the prevalence of POAG was similar 
to that found in the Tajimi Study of Japanese subjects. Multivariate logistic regression analysis 
demonstrated that older age ($60 years, odds ratio [OR]: 3.49), lower diastolic blood pressure 
(#58 mmHg, OR: 2.11), higher intraocular pressure ($19 mmHg, OR: 4.12), and lower ocular 
perfusion pressure (#34 mmHg, OR: 5.78) were associated with increased risk of having POAG. 
These findings may be relevant for identifying high risk groups.
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Introduction
Glaucoma is the leading cause of blindness, and 22.5 million people worldwide are 
estimated to suffer from it. The Tajimi screening study estimated that the prevalence 
of primary open-angle glaucoma (POAG) in Japanese subjects older than 40 years 
was 3.9%, of which 93.3% were previously undiagnosed.1 There is good evidence that 
age, family history, intraocular pressure (IOP), and African ancestry are risk factors 
for POAG.2–4 To better identify persons at risk for developing glaucoma, it is very 
important to determine what other risk factors for POAG also exist.
According to the vascular hypothesis of POAG pathogenesis,5 low blood pressure 
(BP) relative to IOP could lead to low ocular perfusion pressure (OPP), thus impair-
ing perfusion of the optic nerve and causing glaucomatous loss of the visual field. In 
this context, vascular factors have been investigated with attention to BP and OPP.6–10 
Recently, the population-based cohort study11,12 revealed that low systolic BP and low 
OPP were risk factors for POAG. However, there are only a few studies that have reported 
associations between POAG and BP-related factors in Japanese13 and other Asians.14,15
Recently, we conducted a community health checkup project in the city of Akita, 
located in northeastern Japan. The project involved glaucoma screening as well as 
general physical examinations. The purpose of this study was to identify the systemic 
and ocular risk factors associated with POAG in this population.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Subjects and methods
This was a cross-sectional study in an institutional setting. 
Subjects older than 30 years were recruited at an annual 
community health checkup project held in the city of Akita 
(population 325,537), the capital of Akita Prefecture, Japan. 
A total of 1173 subjects participated in the comprehensive 
examinations from September 10, 2007 to October 26, 2007. 
Of these, 710 individuals underwent glaucoma screening. All 
of the participants were ethnically Japanese.
This study was performed after approval by the Ethics 
Committee of Akita Prefecture Health Care Foundation. 
All study procedures adhered to the principles outlined in 
the Declaration of Helsinki for research involving human 
subjects, and all participants gave written informed consent 
for this research prior to their participation.
Screening examination
The screening examination included the recording of   systemic 
and ocular disorder history, height, weight, blood hemoglobin 
A1c (HbA1c) status, alanine aminotransferase (ALT), serum 
cholesterol, and BPs. The initial noncontact ocular examination 
was conducted by trained non-  ophthalmologists and included 
measurement of refraction and keratometry (KR-8100PA; 
Topcon, Tokyo, Japan), IOP by noncontact pneumotonometry 
(Topcon CT-90A), angle width   (Scanning Peripheral Anterior 
Chamber Analyzer; Takagi Seiko, Nagano, Japan), non-my-
driatic optic disk photography by stereoscopic fundus camera 
(30° angle, 3-DX/NM; Nidek, Gamagori, Japan), and confocal 
laser scanning tomography (Retina Tomograph II, software 
v 3.0; Heidelberg Instruments, Heidelberg, Germany). IOP 
was measured three times, and the mean value was used.
Definitive examination
A definitive examination was performed when a subject 
was suspected to have glaucoma based upon the findings 
of the   initial noncontact ocular examination. The defini-
tive examination consisted of the following procedures: 
slit-lamp biomicroscopy, Goldmann applanation tonom-
etry,   gonioscopy, and optic nerve head evaluation using 
a   Goldmann three-mirror lens (Haag-Streit International, 
Koeniz,   Switzerland) and a visual field test with the Humphrey 
Field Analyzer II 24-2 SITA Standard Program (Carl Zeiss 
Meditec Inc, Dublin, CA). Diagnosis of glaucoma was made 
based on optic disk appearance, including cup-to-disk ratio, 
rim width, nerve fiber layer defect, the visual field test, and 
the clinical records that were obtained through screening and 
definitive examinations. When present or suspected, glaucoma 
was categorized based upon the criteria of previous population 
studies (Table 1).1,16 In the definitive diagnosis, anomalous 
disks, including tilted disks, were carefully excluded.
Assessment of risk factors
The systemic variables of age, gender, body mass index 
(BMI), systolic (SBP) and diastolic blood pressure (DBP), 
diagnosis of hypertension, blood pressure-lowering treat-
ment, diabetic status (glycated hemoglobin, HbA1c $ 5.8% 
and/or previous diagnosis as diabetes mellitus),17 liver dys-
function (ALT $ 40 IU and/or previous diagnosis as liver 
dysfunction), and hypercholesterolemia were selected as pos-
sible risk factors. BMI was calculated as weight (kilograms) 
divided by the height (meters) squared. Blood pressure was 
measured after participants had been seated comfortably 
for at least 5 minutes. A single measure of SBP and DBP 
was used. Hypertension was defined using the 2003 World 
Health Organization guideline18 with SBP $ 140 mmHg or 
DBP $ 90 mmHg. Subjects who had a history of hyperten-
sion medication were also defined as having hypertension. 
Hypercholesterolemia was defined when cholesterol lev-
els were greater than the upper limit of the normal range 
(220 mg/dL).19
Table 1 The criteria for primary open-angle glaucoma diagnosis
Category 1
The vertical cup-to-disk ratio of the optic nerve head is 0.7 or more, or the rim width at the superior portion (11–1 o’clock) or the inferior portion  
(5–7 o’clock) is 0.1 or less of the disk diameter, or the difference of the vertical cup-to-disk ratio is 0.2 or more between both eyes, or a nerve fiber  
layer defect is found, and the hemifield-based visual field abnormality is compatible with optic disk appearance or nerve fiber layer defect.
Category 2
When the visual field test is not reliable or available, the cup-to-disk ratio of the optic nerve head is 0.9 or more, or the rim width at the superior  
portion (11–1 o’clock) or the inferior portion (5–7 o’clock) is 0.05 or less of the disk diameter, or the difference of the vertical cup-to-disk ratio  
is 0.3 or more between both eyes.
Glaucoma suspect
When the cup-to-disk ratio of the optic nerve head is 0.7 or more but less than 0.9, or the rim width at the superior portion (11–1 o’clock) or the  
inferior portion (5–7 o’clock) is 0.1 or less but more than 0.05 of the disk diameter, or the difference of the vertical cup-to-disk ratio is 0.2 or more 
but less than 0.3 between both eyes, or the nerve fiber defect is found, and the visual field test is not reliable or available or does not show  
hemifield-based compatible defect, the eye is diagnosed with suspected glaucoma.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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In addition, the ocular variables of IOP, OPP, and   myopia 
were selected for study. Myopia was defined as myopic 
spherical equivalent (SE) ,−1.0 diopter. If only one eye of 
the POAG patient was affected, the IOP, OPP, or SE was 
defined as the value of the glaucomatous eye. For control 
subjects and for bilateral POAG patients, the IOP was defined 
as the highest mean value in either eye. By contrast, OPP and 
SE were defined as the lowest value in either eye. The OPP 
was calculated as 2/3(mean arterial pressure) − IOP, where 
the mean arterial pressure = DBP + 1/3(SBP − DBP).
Data analysis
All of the participants’ private information was kept in the 
protection of the Department of Ophthalmology, Akita 
Graduate University Faculty of Medicine. The data were 
double-checked and analyzed using the Statistical Package 
for the Biosciences (v 9.53; SPBS, Nankodo Publisher, 
Tokyo, Japan) on a personal computer. Systemic and oph-
thalmologic data of all participants diagnosed with definitive 
POAG were analyzed in the present study.
The prevalence of glaucoma and 95% confidence interval 
(95% CI) were calculated for each age group. To compare 
prevalence of POAG in our population with that in the 
Tajimi Study population,1 we determined the age-specific 
risk of POAG using a standardized mortality ratio (SMR). 
The SMR for POAG was the age-specific ratio between the 
observed number of POAG subjects in the study population 
and the expected number of POAG subjects calculated from 
the Tajimi study population. The age group of 30–39 years, 
including 42 normal persons and one POAG patient, was 
excluded from our analysis because the Tajimi Study did 
not include comparable data.
Continuous variables were recorded as means ± standard 
deviations. For the assessment of risk factors, mean values 
were compared by Student’s t-test and frequencies by the 
chi-square test. A control group was selected in this study 
population, and consisted of 634 participants who did not 
have glaucoma or suspected glaucoma, and who had no other 
ocular diseases including congenital disk anomalies that 
could affect the disk shape.3 We estimated the multivariate-
adjusted odds ratios (OR) and the 95% CI for each potential 
risk factor by using logistic regression analysis. Explanatory 
variables included in the analyses were age, gender, BMI, 
SBP, DBP, hypertension, blood pressure-lowering treatment, 
diabetic status, liver dysfunction, hypercholesterolemia, IOP, 
OPP, and myopia. Continuous data such as age, DBP, IOP, 
and OPP were analyzed as categorical variables using quartile 
values based on the study population. These risk factors were 
adjusted for age, gender, blood pressure-lowering treatment, 
IOP, and OPP. For all analyses, P-values were two-sided 
and were considered statistically significant when the values 
were less than 0.05.
Results
The average age of all 710 participants (384 male, 326 
female) was 54.7 ± 9.8 years. Of the 710 participants exam-
ined in the initial screening, 163 (23.0%) were referred for 
definitive examination, but 29 declined or were unable to 
participate. After definitive examination, 29 of the 134 par-
ticipants were diagnosed with glaucoma, and 29 participants 
with suspected glaucoma. Previously undiagnosed glaucoma 
was present in 26 of the 29 subjects with glaucoma (89.6%). 
Of the 29 patients with glaucoma, 26 had POAG. The other 
three had primary angle-closure glaucoma and were not 
included in this study. The prevalence of all glaucoma in each 
age group was shown in Table 2. The prevalence of POAG 
was 3.7% (95% CI: 2.8%–5.5%), and 24 were diagnosed 
with Category 1 disease and two with Category 2 disease. 
In 96.2% of glaucoma patients, the IOP was 21 mmHg or 
less. There was no significant difference in the prevalence 
of POAG between the present study and the Tajimi Study 
based upon the SMR, 1.28 (P . 0.05; Table 3).
There were no statistical differences between non-POAG 
subjects and POAG patients in gender, BMI, SBP, history or 
presence of hypertension, blood pressure-lowering   treatment, 
diabetic status, liver dysfunction, serum   cholesterol, 
Table 2 Age-specific prevalence of all glaucoma
Age groups 
(years)
Primary open-angle glaucoma patients/age population (%, 95% confidence interval)
Male Female All
30–39 1/22 (4.5%, 0.1–22.5) 0/21 (0.0%, –) 1/43 (2.3%, 0.1–12.3)
40–49 0/112 (0.0%, –) 3/104 (2.9%, 0.6–8.2) 3/216 (1.4%, 0.3–4.0)
50–59 5/140 (3.6%, 1.2–8.1) 5/123 (4.1%, 1.3–9.2) 10/263 (3.8%, 1.8–6.8)
60–69 8/75 (10.7%, 4.7–19.9) 3/58 (5.2%, 1.1–14.4) 11/133 (8.3%, 4.2–14.3)
70 and older 2/35 (5.7%, 5.7–19.2) 2/20 (10.0%, 1.2–31.7) 4/55 (7.3%, 2.0–17.6)
All subjects 16/384 (4.2%, 2.4–6.7) 13/326 (4.0%, 2.1–6.7) 29/710 (4.1%, 2.8–5.8)Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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and myopia (Table 4). The mean age of POAG patients, 
58.8 ± 10.6 years, was higher than that of non-POAG subjects 
(P = 0.008). The IOP of POAG patients, 17.2 ± 3.3 mmHg, 
was higher than that of non-POAG subjects, (P , 0.001; 
Table 4), while the DBP and OPP, 61.9 ± 9.5 mmHg and 
41.1 ± 3.0 mmHg respectively, were lower than in non-POAG 
subjects (P = 0.025 and 0.035, respectively).
Multivariate logistic regression analysis of possible 
confounders for POAG demonstrated that gender, BMI, 
hypertension, blood pressure-lowering treatment, diabetic 
status, liver dysfunction, hypercholesterolemia, and myo-
pia were unrelated to risk (Table 5). By contrast, older age 
($75th percentile, 60 years old), lower DBP (#25th percen-
tile, 58 mmHg), higher IOP ($75th percentile, 19 mmHg), 
and lower OPP (#25th percentile, 34 mmHg) significantly 
improved the discrimination between POAG patients and 
controls (Table 6).
Discussion
In our cross-sectional examination of Japanese subjects 
who participated in the community health screening, the 
  prevalence of POAG was 3.7%. Among those with POAG, 
the rate of previously undiagnosed glaucoma was 89.6%. 
After adjusting for age, the prevalence of POAG was similar 
to the results of the Tajimi Study of Japanese subjects. In the 
assessment of risk factors between non-glaucoma participants 
and POAG patients, we showed that lower DBP and lower 
OPP were significant in addition to the established risk fac-
tors of age and IOP. These findings indicate a multifactorial 
etiology of POAG.
The finding that low DBP is a risk factor for POAG 
is in agreement with a recent review, which concluded 
that hypotension is a stronger POAG risk factor than 
  hypertension.20 Lower BP is associated with increased optic 
disk cupping and a thinner neuroretinal rim in persons 
without glaucoma,21 thereby strengthening the possibility of 
a vascular link to glaucoma.22 Lower ocular perfusion pres-
sure in our study was also significantly related to POAG risk. 
Similar results were found in various other epidemiologic 
studies in which low perfusion pressures are a consistent 
finding.6–12 As summarized in various reviews,10,23,24 lower 
perfusion pressures at the optic disk would compromise 
Table 3 expected and observed number of POAg and standardized mortality ratio (sMr) in relation to age
Age (years) Examined  
number
Prevalence of POAG  
in Tajimi
Expected  
number
Observed  
number
SMR Statistical  
significance
40–49 199 2.0% 3.98 3 0.75 ns
50–59 242 2.7% 6.53 8 1.23 ns
60–69 126 4.7% 5.92 11 1.86 ns
70– 54 7.6% 4.10 4 0.98 ns
All 621 3.9% 20.53 26 1.28 ns
Note: NS means there is no statistically significant difference in the prevalence of POAG between the present study and the Tajimi study.
Table 4 Differences in main characteristics between control and POAg
Control POAG P value
systemic
  Age (years), mean ± sD 53.4 ± 9.9 58.8 ± 10.6 0.008
  gender (male) 348 15 0.84
  Body mass index (kg/m2) 2.35 ± 3.3 23.6 ± 3.2 0.58
    systolic blood pressure (mmhg) 112.6 ± 19.0 115.0 ± 17.9 0.51
    Diastolic blood pressure (mmhg) 68.2 ± 12.9 61.9 ± 9.5 0.025
  hypertension 125 5 0.98
    Blood pressure-lowering treatment 120 5 0.99
  Diabetic status 54 2 0.97
  Liver dysfunction 94 4 0.99
  Cholesterol (mg/dL) 211.1 ± 33.2 211.0 ± 31.2 0.90
Ocular
    Intraocular pressure (mmhg) 15.0 ± 2.9 17.2 ± 3.3 P , 0.001
    Ocular perfusion pressure (mmhg) 43.2 ± 5.0 41.1 ± 3.0 0.035
  Myopia 326 11 0.96
Abbreviations: POAg, primary open-angle glaucoma; sD, standard deviation.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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ocular blood flow and thus lead to glaucomatous damage. In 
this context, we also examined the effects of blood pressure-
lowering   treatment, but found no associations with POAG, 
supporting the conclusion that lower perfusion pressures 
are the important risk factor. The other demographic factors 
investigated in this study, gender, BMI, SBP, a history or pres-
ence of hypertension, diabetic status, liver dysfunction, serum 
cholesterol, and myopia, were not associated with POAG in 
our analyses. Our result concerning myopia is inconsistent 
with a previous report in Japanese.25
There are several limitations in the present analyses. 
First is the small sample size, which resulted in estimates 
of association with relatively broad confidence intervals. 
  Second, this study was not a population-based survey because 
the subjects who participated may have been highly inter-
ested in glaucoma. Thus to a degree, they were self-selected 
to participate in the screening, and may not have been 
representative of the general population. This could have 
  introduced a selection bias resulting in an overestimation of 
the prevalence of POAG. Third, we did not perform definitive 
examinations of participants whose eyes appeared normal in 
the initial screening examination. Therefore, some subjects 
with glaucoma may have been overlooked, resulting in an 
underestimation of the prevalence of POAG. In the present 
study, we excluded tilted disks from analysis to have precise 
diagnosis. However, there is a potential problem in exclud-
ing such eyes, as myopia is thought to be a risk factor for 
glaucoma: we could be underestimating the prevalence of 
glaucoma.26 Finally, there were several factors not included 
in the present analysis but reported to be associated with the 
development of POAG, such as systemic medications,9,27 
other ocular diseases,9 and computer use.28 Family history 
of glaucoma is associated with the development of the 
condition;29–32 however, we obtained only limited information 
regarding family histories of glaucoma.
Because of the irreversible nature of glaucoma, early 
disease detection through screening will likely provide a 
substantial benefit by reducing blindness. However, the 
value of glaucoma screening has been a topic of debate for 
many years. Prior evaluations of screening effectiveness have 
concluded that there is insufficient economic evidence to 
recommend screening for POAG.33 Since screening is sensi-
tive to the prevalence of glaucoma in the study population,34 
identifying and targeting high-risk patients should improve 
the program’s cost-effectiveness. The present study has 
  proposed potential risk factors for POAG. These include 
Table  5  Adjusted  odds  ratios  of  possible  confounders  for 
POAg
Adjusted odds  
ratio*
95% confidence  
interval
gender
  Male 1.00 reference
  Female 1.69 0.76–3.75
Body mass index
 , 25 1.00 reference
 $ 25 1.73 0.76–3.99
hypertension
  no 1.00 reference
  Yes 1.07 0.41–2.78
Blood pressure-lowering treatment
  no 1.00 reference
  Yes 9.06 0.10–14.8
Diabetic status
  no 1.00 reference
  Yes 1.58 0.35–7.14
Liver dysfunction
  no 1.00 reference
  Yes 1.01 0.30–3.82
hypercholesterolemia
  Chr , 220 mg/dL 1.00 reference
  Chr $ 220 mg/dL 1.13 0.51–2.55
Myopia
  no 1.00 reference
  Yes 1.23 0.89–1.45
Note: *Based on multivariate logistic regression analysis adjusted for age, gender, 
diastolic blood pressure. intraocular pressure, and ocular perfusion pressure.
Table 6 Odds ratios of risk factors for POAg
Odds ratio1 
(95% confidence limit)
Adjusted odds ratio2 
(95% confidence limit)
Adjusted odds ratio3 
(95% confidence limit)
Age $ 60 years 2.56 (1.22–5.41) 3.49 (1.41–8.62) 3.54 (1.42–8.81)
DBP # 58 mmhg 2.08 (1.21–5.45) 2.11 (1.69–6.67) 2.50 (1.11–10.05)
IOP $ 19 mmHg 4.19 (1.91–9.16) 4.12 (1.35–12.56) 3.38 (1.02–11.18)
OPP # 34 mmhg 5.44 (1.11–8.26) 5.78 (1.21–7.92) 5.54 (1.12–6.18)
Notes: 1Based on Yates chi-square test; 2based on multivariate logistic regression analysis adjusted for age, gender, diastolic blood pressure, intraocular pressure, and ocular 
perfusion pressure; 3based on multivariate logistic regression analysis adjusted for age, gender, BMI, diastolic blood pressure, hypertension, hypercholesterolemia, intraocular 
pressure, and ocular perfusion pressure.
Abbreviations: DBP, diastolic blood pressure; IOP, intraocular pressure; OPP, ocular perfusion pressure.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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older age, higher IOP, lower diastolic pressure, and lower 
ocular perfusion pressure. These risk factors may provide 
effective guidelines for targeting community glaucoma 
screening to the highest risk populations.
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